Agilent Technologies, Inc. (A): Price and Financial Metrics
Agilent Technologies, Inc. (A)
Today's Latest Price: $97.69 USD
Updated Sep 25 4:02pm
Add A to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 58 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
A Stock Summary
- With a market capitalization of $29,702,550,236, Agilent Technologies Inc has a greater market value than 93.71% of US stocks.
- The price/operating cash flow metric for Agilent Technologies Inc is higher than 90.08% of stocks in our set with a positive cash flow.
- The volatility of Agilent Technologies Inc's share price is greater than that of merely 11.18% US stocks with at least 200 days of trading history.
- Stocks that are quantitatively similar to A, based on their financial statements, market capitalization, and price volatility, are RMD, CERN, FTV, BAX, and CMI.
- Visit A's SEC page to see the company's official filings. To visit the company's web site, go to www.agilent.com.
A Stock Price Chart Technical Analysis Charts
A Price/Volume Stats
| Current price | $97.69 | 52-week high | $103.66 |
| Prev. close | $96.34 | 52-week low | $61.13 |
| Day low | $95.77 | Volume | 1,028,618 |
| Day high | $98.13 | Avg. volume | 1,969,531 |
| 50-day MA | $97.88 | Dividend yield | 0.75% |
| 200-day MA | $86.05 | Market Cap | 30.12B |
Agilent Technologies, Inc. (A) Company Bio
Agilent Technologies provides bio-analytical solutions and services to the life sciences, diagnostics and genomics, chemical analysis, communications, and electronics industries worldwide. The company was founded in 1999 and is based in Santa Clara, California.
A Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $97.69 | $26.94 | -72% |
Below please find a table outlining a discounted cash flow forecast for A, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Agilent Technologies Inc ranked in the 18th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Agilent Technologies Inc ended up being:
- As a business, A is generating more cash flow than 74.3% of positive cash flow stocks in the Healthcare.
- The business' balance sheet suggests that 7% of the company's capital is sourced from debt; this is greater than merely 17.52% of the free cash flow producing stocks we're observing.
- A's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 41.5% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -73% |
| 1% | -72% |
| 2% | -72% |
| 3% | -72% |
| 4% | -71% |
| 5% | -71% |
BIO, DHR, AZN, BHC, and CNMD can be thought of as valuation peers to A, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...